ACS Boston 2018: Day 1

All this week, MedChemNet is bringing you content direct from the National Meeting and Exposition of the American Chemical Society in Boston; take a look at some of our highlights.

Thumb untitled design
Aug 19, 2018
Daily update

We've arrived at ACS Boston!

The conference is already well and truly underway, kicking off with streams focusing on emerging trends in target identification, small molecule treatments for inflammatory bowel disease and 'DNA, RNA and Inorganic Drugs'.

Highlights include a talk by Justin Jeff Wilson (Cornell University, NY, USA), who presented novel research on rhenium as an alternative to platinum for the treatment of cancer, and Robin Bevernaegie (Université catholique de Louvain, Ottignies-Louvain-la-Neuve, Belgium) discussing the theranostic applications of highly photo reactive Ir(III) complexes. 

Today's featured guest

Freya Leask, RegMedNet (London, UK)
Picture of the DayTomorrow's key talk
Confronting the Opioid Epidemic: Novel Treatments for Chronic Pain
We're all set up here at ACS Boston! Come meet us at booth #512.Room 210B, Boston Convention and Exhibition Center
Today's news highlights
Light-activated oxygen could kill antibiotic-resistant bacteria
Research presented at the 256th National Meeting of the American Chemical Society suggests treatment-resistant MRSA could be targeted by light-activated oxygen.
Medium untitled design


A network for the drug discovery and development community, Future Science Group

Your source for the latest news and views from the fields of drug discovery and medicinal chemistry.

No comments yet.